<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_TecMonterrey_GDA_Parts skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:TecMonterrey GDA/Parts</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="menu-wrapper"><H1>TecMonterrey_GDA</H1><DIV class="logo youth-biotech" title="Youth Biotech">Youth Biotech</DIV><DIV class="logo itesm" title="Tecnológico de Monterrey">Tecnológico de Monterrey</DIV><UL class="navigation"><LI><A href="https://2017.igem.org/Team:TecMonterrey_GDA/Description">Project</A></LI><LI><A href="https://2017.igem.org/Team:TecMonterrey_GDA/Description">Description</A></LI><LI><A href="https://2017.igem.org/Team:TecMonterrey_GDA/Project/Justification">Justification</A></LI><LI><A href="https://2017.igem.org/Team:TecMonterrey_GDA/Parts">Parts</A></LI><LI><A href="https://2017.igem.org/Team:TecMonterrey_GDA/Model">Mathematical Model</A></LI><LI><A href="https://2017.igem.org/Team:TecMonterrey_GDA/Entrepreneurship">Entrepreneurship</A></LI><LI><A href="https://2017.igem.org/Team:TecMonterrey_GDA/Demonstrate">Demonstrate</A></LI><LI><A href="https://2017.igem.org/Team:TecMonterrey_GDA/Contribution">Contribution</A></LI></UL><LI><A href="https://2017.igem.org/Team:TecMonterrey_GDA/Applied_Design">Environmental track</A></LI><LI><A href="https://2017.igem.org/Team:TecMonterrey_GDA/Applied_Design">Applied design</A></LI><LI><A href="https://2017.igem.org/Team:TecMonterrey_GDA/Notebook">Notebook</A></LI><LI><A href="https://2017.igem.org/Team:TecMonterrey_GDA/Notebook">Lab Book</A></LI><LI><A href="https://2017.igem.org/Team:TecMonterrey_GDA/Notebook/Diagrams">Diagrams</A></LI><LI><A href="https://2017.igem.org/Team:TecMonterrey_GDA/Safety">BioSafety</A></LI><LI><A href="https://2017.igem.org/Team:TecMonterrey_GDA/Engagement">Human Practices</A></LI><LI><A href="https://2017.igem.org/Team:TecMonterrey_GDA/HP/Silver">Silver</A></LI><LI><A href="https://2017.igem.org/Team:TecMonterrey_GDA/HP/Gold_Integrated">Gold integrated</A></LI><LI><A href="https://2017.igem.org/Team:TecMonterrey_GDA/Engagement">Public Engagement</A></LI><LI><A href="https://2017.igem.org/Team:TecMonterrey_GDA/Collaborations">Collaborations</A></LI><LI><A href="https://2017.igem.org/Team:TecMonterrey_GDA/Team">Team</A></LI><LI><A href="https://2017.igem.org/Team:TecMonterrey_GDA/History">History</A></LI><LI><A href="https://2017.igem.org/Team:TecMonterrey_GDA/Team">Members</A></LI><LI><A href="https://2017.igem.org/Team:TecMonterrey_GDA/Attributions">Atributions</A></LI></DIV><DIV class="content-wrapper"><DIV class="content-wrapper"><DIV class="p-4" style="text-align: center"><H1>Parts</H1></DIV><DIV class="p-4 container" style="background-color: #A9F5D0; border-radius: 0.5rem"><TABLE class="table" style="background-color: #FFFFFF"><THEAD><TR><TH>#</TH><TH>Name</TH><TH>RBS</TH><TH>CDS</TH><TH>Designer</TH></TR></THEAD><TBODY><TR><TD><P>1</P></TD><TD><A href="http://parts.igem.org/Part:BBa_K2434006">BBa_K2434006</A></TD><TD><P>High Copy Number RBS  BBa_B0034</P></TD><TD><P><A href="http://parts.igem.org/Part:BBa_K2434000">fabG BBa_K2434000</A>, <A href="http://parts.igem.org/Part:BBa_K2434001">phaG BBa_K2434001</A>, <A href="http://parts.igem.org/Part:BBa_K2434002">phaC1 BBa_K2434002</A>, <A href="http://parts.igem.org/Part:BBa_K2434003">phaC2 BBa_K2434003</A>, <A href="http://parts.igem.org/Part:BBa_K660004">iLOV BBa_K660004</A></P></TD><TD><P>Diana Bonilla</P></TD></TR><TR><TD><P>2</P></TD><TD><A href="http://parts.igem.org/Part:BBa_K2434008">BBa_K2434008</A></TD><TD><P>BBa_J61100</P></TD><TD><P><A href="http://parts.igem.org/Part:BBa_K2434004">araC BBa_K2434004</A>, <A href="http://parts.igem.org/Part:BBa_K2434005">ACC BBa_K2434005</A></P></TD><TD><P>Santi Ochoa</P></TD></TR></TBODY></TABLE><DIV style="text-align: center;"><H2 class="p-2">BBa_K2434006</H2></DIV><H4><B>Description</B></H4><DIV class="p-2 text-justify"><P>The aim of the following construct is to synthesize polyhydroxyalkanoates from available carbon sources.  </P><H4><B>Design considerations</B></H4><DIV class="p-2 text-justify"><P> The genes which were considered for the design were the ones that involved PHA production starting at 3-ketoacyl-ACP, which is in Pseudomonas putida KT2440 and in most E.coli strains. The first gene in the construct is fabG that turns  3-ketoacyl-ACP into (S)-3-hydroxyacyl-ACP, and phaG uses it to produce  (R)-3-hydroxyacyl-CoA, the precursor for PHA. The following genes are phaC1 and phaC2, which are both synthases for polyhydroxyalkanoates. All the sequences have been optimized for their use in E.coli BL21 and restriction sites have been removed. </P></DIV><H4><B>Promoters</B></H4><DIV class="p-2"><A href="http://parts.igem.org/Part:BBa_I712074"> T7 Promoter BBa_I712074 </A><P>To use this promoter we have to transform an E.coli BL21</P><P>This promoter is repressed during the exponential phase of the growth curve. It can be activated with IPTG (isopropyl-beta-d-thiogalactopyranoside) a synthetic sugar that works as an inductor. </P></DIV><H4><B>Terminators</B></H4><DIV class="p-2 text-justify"><P><A href="http://parts.igem.org/Part:BBa_B0010">BBa_B0010</A> and <A href="http://parts.igem.org/Part:BBa_B0012">BBa_B0012</A></P></DIV><DIV style="text-align: center;"><H2 class="p-2">BBa_K2434008</H2></DIV><H4><B>Description</B></H4><DIV class="p-2 text-justify"><P> The main function of this biobricks is to regulate and optimize carbon usage necessary for PHA synthesis.</P></DIV><H4><B>Promoters</B></H4><DIV class="p-2"><P><A href="http://parts.igem.org/Part:BBa_I13453">pBad BBa_I13453</A>, <A href="http://parts.igem.org/Part:BBa_J23119">BBa_J23119</A></P></DIV><H4><B>Design considerations</B></H4><DIV class="p-2 text-justify"><P>The ACC gene encodes for Acetyl-CoA Carboxylase, which has been shown to increase the synthesis of fatty acids, and since this pathway will be altered to include PHA synthesis it will also increase PHA production.But an overexpression of ACC leads to a lack of carbon necessary for the Krebs cycle. In order to avoid this problem ACC is controlled by the pBad promoter, allowing for a normal metabolism in the absence of arabinose.The iLOV protein will be used as a reporter for the expression of ACC.</P></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>